The Clinical Development & Regulatory Affairs team at AOP Health is responsible for overseeing the progression of innovative therapies from concept to market, ensuring compliance with regulatory standards throughout the development process. This team conducts vital preclinical and clinical trials, manages drug safety and quality, and liaises with regulatory bodies to facilitate the approval of therapies for rare diseases and critical care, ultimately aiming to enhance patient outcomes and access to treatment.
Bianca Tan
International Therapeutic Area...
Blanka Pranjić
Senior Preclinical Development...
Dr. Christoph Klade
Director Research And Developm...
Heike Knausz-Kuttner
Senior Preclinical Development...
Ken Miyama
Drug Safety Manager
Manuel Naylor
Senior CMC Lead – CMC Developm...
Obereigner Friedrich...
Senior Regulatory Manager Bei ...
Sandra Urban
Drug Safety Manager
Swantje Winkler
Senior Preclinical Development...
Szabolcs Biró
Team Lead Clinical Development...
View all